Fragrance Foundation 28th Annual FiFi Award Winners
This article was originally published in The Rose Sheet
Executive Summary1See related information
You may also be interested in...
Biocon-Mylan press ahead with plans to broaden patient access in the US to biosimilar pegfilgrastim and are enthused with the initial uptake for their trastuzumab biosimilar ahead of more upcoming competition. A mid-2020 US launch for partnered insulin glargine is also on course.